In this study, we established an in vitro model of cisplatin-induced MC damage and demonstrated that cochlear marginal cell pyroptosis is induced by cisplatin via NLRP3 inflammasome activation, which may provide a novel intervention target for the prevention and treatment of cisplatin-induced hearing loss. This evidence concerns the gene NLRP3 and hearing loss disorder.